Introducing the Optimum TAV
Designed for durability.
Thubrikar Aortic Valve announces successful 30-day outcomes in European feasibility study
A conversation on TAV durability
Dr. Jeffrey Popma, Dr. Danny Dvir, and Dr. Mano Thubrikar discuss at the Baim Institute of Clinical Research in Boston